Prabhakar Rajan

This study profiles cell-free RNAs in prostate cancer patients on active surveillance to identify differences between stable disease and progression to radical prostatectomy.

This study identifies FOXA1 as a key regulator of splicing-related proteins in prostate cancer, linking its dysregulation to poor patient outcomes and suggesting therapeutic targeting of splicing pathways.

This study profiles cell-free DNA in metastatic prostate cancer patients, identifying genomic alterations, microsatellite instability, and clonal hematopoiesis as potential biomarkers.